| Entry |
|
|---|
| Name |
Nalidixic acid (JP16/USP/INN);
NA;
NegGram (TN)
|
|---|
| Formula |
C12H12N2O3
|
|---|
| Exact mass |
232.0848
|
|---|
| Mol weight |
232.2353
|
|---|
| Structure |
     |
|---|
| Activity |
Antibacterial
|
|---|
| Remark |
Same as: Therapeutic category: ATC code: |
|---|
| Target |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
624 Synthetic antibacterials
6241 Pyridonecarboxylic acids
D00183 Nalidixic acid (JP16/USP/INN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01M QUINOLONE ANTIBACTERIALS
J01MB Other quinolones
J01MB02 Nalidixic acid
D00183 Nalidixic acid (JP16/USP/INN)
Antiinfectives [BR:br08307]
Antibacterials
Nucleic acid synthesis inhibitor
type II topoisomerase (DNA gyrase, topoisomerase IV) inhibitor [KO:K02469 K02470 K02621 K02622]
Other quinolones
Nalidixic acid [ATC:J01MB02]
D00183 Nalidixic acid (JP16/USP/INN)
 |
|---|
| Other DBs |
CAS: 389-08-2 PubChem: DrugBank: PDB-CCD: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 17
1 C8y C 24.4685 -17.3910
2 C8y C 24.4685 -15.9905
3 N4y N 25.6963 -18.1008
4 N5x N 23.2472 -18.1071
5 C8y C 25.6836 -15.2743
6 C8x C 23.2472 -15.2936
7 C8x C 26.8773 -17.3975
8 C1b C 25.6899 -19.4883
9 C8y C 22.0386 -17.3910
10 C8y C 26.9113 -15.9776
11 O5x O 25.6770 -13.8803
12 C8x C 22.0386 -15.9905
13 C1a C 24.4878 -20.1854
14 C1a C 20.8301 -18.0816
15 C6a C 28.1134 -15.2807
16 O6a O 29.3221 -15.9713
17 O6a O 28.1706 -13.8868
BOND 18
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 2
9 5 10 1
10 5 11 2
11 6 12 2
12 8 13 1
13 9 14 1
14 10 15 1
15 15 16 1
16 15 17 2
17 7 10 2
18 9 12 1
|
|---|
